chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 30-Mar-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 30-Mar-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 30-Mar-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 30-Mar-2022) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     Acute illness at the time of vaccination and upto 1 month before was unknown. Chronic and long-standing health conditions at the time of vaccination was unknown.     On 30-Mar-2022 at 2:06 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 30-Mar-2022 at 2:06 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 30-Mar-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 30-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 30-Mar-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 30-Mar-2022) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  Ethnicity was provided. Vaccine administration time 14:06:43 The patient was administered booster dose that went into 2 to 8 Celsius thaw state on or above 24-Dec -2021. This vaccine was administered up until its manufacturing expiry date of 04-Apr-2022. No treatment information was provided.
Sharp decline in total health beginning day after vaccine, very possibly could be general decline unrelated to vaccine. Pt requested we make report.
they were diagnosed with COVID last Friday; they were diagnosed with COVID last Friday; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "they were diagnosed with COVID last Friday". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (03Aug2023) Unknown results, notes: they took the COVID test yesterday. Clinical course: Caller mentioned they were diagnosed with COVID last Friday and took the COVID test yesterday and was wondering how soon after COVID can they receive a new COVID 19 vaccine to get updated with it and had no current symptoms and was been 7 days since the diagnosis. Caller then added they took a two stage shot and a booster from Pfizer.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.
On 09/15/2022 I received my Covid-19 vaccine. On 02/13/2023 I started having urinary frequency and pain. After reaching out to my provider I was prescribed CIPRO. Symptoms lasted about 3 weeks.
Report 2001025697-1 describes high-pitched screaming in a 2 month old male who received Infanrix. Medical history, concurrent conditions, and concurrent medications were not specified. There was no illness at the time of vaccination. On 10/17/2001, the infant received his first injection of Infanrix. On that date, he also received his first injections of Haemophilus influenzae type b conjugate vaccine and inactivated poliomyelitis virus vaccine. Later that day, an unspecified time post-immunization, the infant experienced high-pitched screaming that lasted one to two hours. Additionally, he experienced jumpiness and irritability. The irritability was treated with Tylenol from 10/17/2001 to 10/18/2001. The events resolved on 10/17/2001. The reporter considered the events to be of moderate intensity and possibly related to Infanrix administration. The infanrix immunization series was discontinued.
DTP given 10JUN91, inconsolable screaming for 24hrs, t101-102;
Initial information received on 14-Nov-2018 regarding an unsolicited valid non-serious case received from a nurse via other company (Merck). This case involves a female patient (age not reported) who experienced itching at the injection site, large area of swelling, redness, warmth at the injection site, swelling and redness of her face and swelling and redness of her face, while she received vaccine INFLUENZA VACCINE. The patient's past medical history and concomitant medication were not provided. On 31-Oct-2018, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in the left arm. On an unknown date, The patient developed a non-serious itching at the injection site (vaccination site pruritus) following the administration of INFLUENZA VACCINE. On an unknown date, The patient developed a non-serious large area of swelling, redness, warmth at the injection site (vaccination site inflammation) following the administration of INFLUENZA VACCINE. On 01-Nov-2018, The patient developed a non-serious swelling and redness of her face (face oedema) 01 day following the administration of INFLUENZA VACCINE. On 01-Nov-2018, The patient developed a non-serious swelling and redness of her face (erythema) 01 day following the administration of INFLUENZA VACCINE. Final diagnosis was swelling and redness of her face, swelling and redness of her face, large area of swelling, redness, warmth at the injection site and itching at the injection site. No lab test was reported. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Recovered / Resolved on an unknown date for itching at the injection site, as Recovering / Resolving for large area of swelling, redness, warmth at the injection site, as Recovered / Resolved on an unknown date for swelling and redness of her face and as Recovered / Resolved on an unknown date for swelling and redness of her face.
Debilitating headache, bodily fatigue, soreness at injection site, partial loss of mobility of injected limb, nausea, vomiting. Adverse events subsided partially, or mostly, after 24 hours.
Gave a Hep B, when not needed.  No adverse reaction noted by the patient.
Red rash over most of my body; no blisters but itchy. Treated with hydrocortisone and antihistamine. Resolved after about 6 days.
Minutes after receiving the vaccine, patient reported feeling ill and hearing ringing in her ears. Patient appeared pale. No loss of consciousness. Patient remained alert and oriented to time and place. Patient was lowered to the floor with feet elevated. HR 78 O2 Sat 99%. Radial pulse 3+. Patient was given some crackers and water. After 5 minutes, patient reported improvement and sat up on the floor.  She reported a return of the dizziness after one minute and resumed lying down. EMS was called.  Blood pressure 108/72. After 20 minutes of resting on the floor patient moved to a seated position in a chair, which she tolerated well.  After 10 minutes she stood, which she tolerated well. Paramedics discharged to home, recommending follow up with PCP. Patient left under own power.
This spontaneous report as received from the patient's mother refers to her daughter, a 17 year old female patient. No concurrent conditions or medical history were reported. On 05-MAY-2015, the patient was vaccinated with the first dose of GARDASIL (lot # and expiration date were not provided) intramuscular. Concomitant therapies included NORTREL. On 05-MAY-2015, the patient experienced vomiting and asthenia reported as "felt very weak" after receiving the first dose of GARDASIL. On an unspecified date, the patient received ZOFRAN for treatment of vomiting and asthenia. The patient did not seek medical attention. No laboratories diagnostic studies were performed. It was not confirmed if the subsequent doses of GARDASIL would be administered, although the reporter stated that she requested for the GARDASIL, to be discontinued. The outcome of vomiting and asthenia was reported as not recovered at the time of the report. The reported did not assess the relatedness of GARDASIL to vomiting and asthenia. Additional information has been requested.
Patient felt dizzy, and appeared pale post dose 1 of Pfizer COVID vaccine 5-11. He was given enhanced observation, hydrated and symptoms improved.
6 hours after shot I began to feel dizzy and nauseous. The next day I had fever, chills, body aches, fatigue, excruciating headache, muscle weakness, chest pain, trouble breathing. These symptoms were most severe that following day, but have lingered for over TWO  WEEKS. I've been to the doctor twice, had multiple tests, two negative covid tests, and xrays done and all that I have are "normal" results and still feeling awful. I need answers. I need someone to tell me whether other people are suffering like this weeks after their shot. there is no other explanation for my symptoms, other than a reaction to this shot. Could someone please reach out to me? Im desperate and don't want anyone else to go through what I am.
woke up the morning of june 18 2021 with a sore/tender arm. it was also inflamed  in the area of my vaccine.  The morning of June 19 2021 I noticed it had spread and still sore/tingly.  At urgent care the skin marked the area to keep an eye on it.
CLOT IN THE LEG; MIGRAINE HEADACHE; TROUBLE SWALLOWING FOR 2  WEEKS; TROUBLE TO YOUR NERVOUS SYSTEM; SINUSES PUSHED BACK; This spontaneous report received from a patient concerned a 65 year old male of unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: degenerative joint disease, sinus, and legally blind, and other pre-existing medical conditions included: Patient had a very very delicate nervous system. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, and batch number: unknown, expiry: unknown)  dose not reported, 1 total administered to right arm on an unspecified date for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced migraine headache, clot in the leg, stated stated vaccine causes trouble to nervous system, trouble swallowing for two weeks, and when asked if he had any allergies, he stated that after the Johnson & Johnson and "sinuses pushed back (all events with dose number in series 1). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from trouble swallowing for two weeks, and the outcome of migraine headache, clot in the leg, trouble to your nervous system and sinuses pushed back was not reported. On 03-JAN-2022, the patient received BNT162 Pfizer vaccine (dose number in series 2) (form of admin not reported, route of admin not reported, and batch number: unknown, expiry: unknown) dose was not reported, for prophylactic vaccination. It was unknown if the patient experienced any adverse event after vaccination with BNT162 Pfizer (dose number in series 2). This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20220207035-COVID-19 VACCINE AD26.COV2.S- clot in the leg, -This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 05-JAN-2015, the patient was vaccinated with an improperly stored dose of ZOSTAVAX subcutaneously, once, lot # K004930, expiration date: 06-MAR-2015 9dose was not reported). There was no adverse effects reported. Administered dose of vaccine experienced the temperature excursion of 38 degrees Fahrenheit for 40 days (reported as 40 days +) since 08-OCT-2014. This is one of several reports received from the same reporter. Lot number K004930 is an invalid lot number for ZOSTAVAX. Additional information has been requested.
tachycardia/heart rate went immediately up to 166; shortness of breath; Felt hot; Felt fuzzy; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of HEART RATE INCREASED (tachycardia/heart rate went immediately up to 166), DYSPNOEA (shortness of breath), HOT FLUSH (Felt hot) and FEELING ABNORMAL (Felt fuzzy) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included Allergy to chemicals (Patient is allergic propylene glycol).    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced HEART RATE INCREASED (tachycardia/heart rate went immediately up to 166), DYSPNOEA (shortness of breath), HOT FLUSH (Felt hot) and FEELING ABNORMAL (Felt fuzzy). At the time of the report, HEART RATE INCREASED (tachycardia/heart rate went immediately up to 166), DYSPNOEA (shortness of breath), HOT FLUSH (Felt hot) and FEELING ABNORMAL (Felt fuzzy) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: normal (normal) Patient went to see a cardiologist who performed some tests on her which was fine..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
3/15 9AM started to have expressive aphasia noticed by family, shaking chills and headache.  Brought to ER. CTH completed and negative. Admitted for monitoring. 3/16 early AM (5am) -seizure like activity and right sided facial droop. CTH negative MRI, EEG pending Fever 102 3/16 7AM.
Fevers Chills Muscle aches Headaches Hoarse voice Diarrhea
Headaches, body aches, and fatigue started in the middle of the night on the 26th/in the early morning of the 27th around 2-3am. These continued throughout the day of the 27th until around 6pm when symptoms subsided. Slight fever also started around the same time, but stopped around 3-4pm of the 27th. I took 400mg of advil once at around 7:00am, and once again at 1:30pm. These helped alleviate some symptoms. At the end of the day on the 27th, most symptoms (except for sore arm) were gone!
feb t104.6 R inj site warm & tender; tx APAP suppository-APAP PO, tepid bath; 21APR pt w/maculopapular rash; rx DPH & APAP 22APR95 9AM; pt to ER dx rash; tx cont w/APAP improving;
Patient received his first dose of Pfizer Covid-19 vaccine. He seemed fine other than being a little nervous and reluctant to receive the shot. The screening questionnaire we conduct with all patients looking to receive vaccination checked out fine - no abnormalities, no prior reactions to any vaccines, no allergies, etc. A few minutes after administering the vaccine, the patient came up to the pharmacy counter and was leaning on it, then proceeded to faint and fall to the floor. He went in and out of consciousness for about a minute before he was able to sit himself up. He also involuntarily urinated. Once he regained consciousness, I gave him a bottle of orange juice and another team member activated EMS. EMS arrived within about 5 to 10 minutes, and checked his vitals. Everything checked out fine. The patient refused to leave with EMS to be admitted to the hospital. After EMS left, he stayed in the pharmacy waiting room and waited for his girlfriend to come picked him up. He was here about 45 minutes total, and seemed fine when he left with her.
PATIENT DEVELOPED FACIAL SWELLING 2 HOURS AFTER INJECTION WAS ADMINISTERED. WENT TO ER GIVEN SOL MEDROL, BENADRYL AND PEPCID, WAS ADMITTED FOR OBSERVATION.
03/01/2021 -Delayed cutaneous hypersensitivity (COVID Arm) itching and rash appeared approximately 11:30am.  The rash corresponds to the injection site and measures +/- 3.5?x2.5?. Itching began subsiding after approximately 3 hours.  03/01/2021 - Redness is still present but is somewhat faded and  ?mottled? in appearance. The diameter has not reduced however..  No treatment. I am continuing to monitor it
Sore Arm and Overall fatigue the next morning. Strange taste in mouth. Metallic like.
48 hrs after vaccine (L) elbow developed a purulent sac that stayed 3-4 days. No with residual bruise 2" x 4 1/2". No temps, no joint pain no loss of ROM.
No Adverse Event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No Adverse Event) in a 6-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR6965B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 04-Dec-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Dec-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used).    No concomitant medications were reported.  The 6 year old patient was accidentally administered with the first primary dose of the Moderna Covid 19 vaccine on 04-Dec-2022 from a vial that expired on 25-Nov-2022.  No treatment medications were reported.
COVID arm (6.5 x 4 inches rash on the arm); Lot of pain in the arm / arm was still sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Lot of pain in the arm / arm was still sore) and RASH (COVID arm (6.5 x 4 inches rash on the arm)) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     Concurrent medical conditions included Broken wrist (The patient has just nine fingers on the hand).    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (Lot of pain in the arm / arm was still sore). On 15-Feb-2021, the patient experienced RASH (COVID arm (6.5 x 4 inches rash on the arm)). On 15-Feb-2021, PAIN IN EXTREMITY (Lot of pain in the arm / arm was still sore) had resolved. At the time of the report, RASH (COVID arm (6.5 x 4 inches rash on the arm)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.    Most recent FOLLOW-UP information incorporated above includes: On 19-Jun-2021: Follow-up received on 19-JUN-2021 contains updated outcome of event "Rash" into Recovered/Resolved.
I developed symptoms of COVID 19 on 12/30/21 with chills, cough, congestion, sore throat, ear ache, loss taste, chest tightness, headaches, joint pain, abdominal pain, fatigue, which lasted 7 to 10 days. I still have a lingering cough and ear ache/clogged/drainage. It has exacerbated diverticulitis attacks.
Information has been received from a physician concerning a 13 month old female with a history of premature birth, cystic hydroma in which she has had multiple surgeries for tube feed insertion and other related surgeries, bronchopulmonary dysplasia and Tracheostomy who on 3/21/02 was inadvertently vaccinated in the left thigh with a dose of varicella virus vaccine live (lot 640722/1149L). On 4/8/02, the pt developed a typical varicella rash. She had approx. 20 lesions on her forehead, chest, abdomen, both groins and the upper extremities and was hospitalized and being treated with IV Acyclovir. It was reported that the physician has DFA + VZV and was planning on collecting another specimen for new analysis. The pt did not have recent exposure to chickenpox or shingles. F/U information from the physician indicated that on 4/8/02, the pt developed a vesicular-papular rash with 20 lesions and scabs on her trunk and lower extremities. Her maximum temperature was 99F. It was reported that other systemic symptoms included respiratory distress and ? bronchiolitis. On 4/11/02, a specimen was obtained from a scabbed vesicle and was sent to the lab for analysis. It was reported that the pt subsequently recovered. Additional information has been requested. Follow up info indicated that the specimen was inadequate to process, negative for B-globin, no strain ID. Additional info has been requested.
Moderna vaccine.  I was fine and active until bed time 2/7/21.  After shower I felt clogged, I did neti pot sinus drain with warm water and hydrogen peroxide  10 to 1.  Went to bed (CPAP) and woke up at 2:30AM with nose running and unable to breath through nostrils.  Got up and used warm compress over eyes and nose for about three minutes and congestion partially cleared.  Upon returning to bed (CPAP} I began to again build up mucous.  Repeated same routine at 06:00AM except returning to bed.  Immediately became congested again.  Took temperature reading 97.3F.  Took Temperature again at 8:AM 96.8 BP 97-168 resp 66
First lifetime episode of what appears to be angioedema - of BL feet only - in absence of cardiac s/s and with labs negative for infection and vasculitis.   Sed mildly elevated.   Feet swelled markedly over a 3-day period starting 4/28/21 and finally resolving about 2 weeks later after course of prednisone.    She has her second case now.  Hereditary angioedema labs pending.
pt stated her left arm was sore about ten minutes after getting the vaccine but then her right arm was also sore in the muscle and then the pain moved down her arm to her wrist.   She became very cold with chills.  She took Tylenol and slept.  During the night her head started hurting.  She took more Tylenol and went back to sleep.  Next day she was very weak and had flu like symptoms.  She had diarhea that evening and still had chills.  After third day she no longer had any temperature but she still had fatigue.  All of her joints were stiff and hurting.  The stiffness and pain was really bad in her knees.  She developed a painful spot on the side of her right knee.  She started taking Motrin.  She went to Urgent Care  on 11/2/21.  She had an XRAY with negative  results.  She was recommended to FU w/ Orthopedic doctor and get an MRI.  She still has pain and limping when she walks.  She feels like the pain is going down from her knee to her calf.